Efficacy of an Irritable Bowel Syndrome Diet in the Treatment of Small Intestinal Bacterial Overgrowth: A Narrative Review
Related Experiment Video
Updated: Aug 30, 2025
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Justyna Paulina Wielgosz-Grochowska1, Nicole Domanski2, Małgorzata Ewa Drywień1
1Department of Human Nutrition, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences, 02-776 Warsaw, Poland.
Abstract:
Small intestinal bacterial overgrowth (SIBO) is highly prevalent in irritable bowel syndrome (IBS). The eradication of bacterial overgrowth with antibiotics is the first-line treatment. However, focusing only on the antimicrobial effects without taking care to improve lifestyle factors, especially dietary patterns, may predispose patients to intestinal microbiota dysfunction. The objective of this study is to determine whether the current recommendations regarding nutrition in IBS are suitable for patients with SIBO. A narrative literature review was carried out using databases, including PubMed, ScienceDirect and Google Scholar. Recent studies indicate that dietary manipulation may have a role in alleviating SIBO gastrointestinal symptoms. A low FODMAP diet proposed for IBS may promote a negative shift in the gut microbiota and deepen the existing state of dysbiosis in SIBO patients. Supplementation with soluble fiber can lessen the symptoms in IBS and SIBO. Targeted probiotic therapy may also increase the effectiveness of antibiotic treatment and regulate bowel movements. Therefore, optimal dietary patterns play a key role in the treatment of SIBO. Based on currently available literature, the potential efficacy of the IBS diet in SIBO is largely hypothetical. Future research is needed to characterize a specific diet for the treatment of SIBO.
Insights
Dietary patterns are crucial for treating small intestinal bacterial overgrowth (SIBO), often linked to irritable bowel syndrome (IBS). Current IBS diets may worsen SIBO dysbiosis, highlighting the need for specific SIBO nutritional strategies.
Area of Science:
- Gastroenterology
- Microbiology
- Nutritional Science
Background:
- Small intestinal bacterial overgrowth (SIBO) is frequently observed in patients with irritable bowel syndrome (IBS).
- Antibiotic therapy is the primary treatment for SIBO, but neglecting lifestyle factors like diet can lead to gut microbiota dysfunction.
- The suitability of current IBS nutritional guidelines for SIBO patients requires investigation.
Purpose of the Study:
- To evaluate whether existing nutritional recommendations for IBS are appropriate for individuals with SIBO.
- To explore the role of dietary interventions in managing SIBO symptoms and gut dysbiosis.
Main Methods:
- A narrative literature review was conducted.
- Searches were performed across major scientific databases: PubMed, ScienceDirect, and Google Scholar.
- Recent studies on dietary manipulation and SIBO were analyzed.
Main Results:
- Dietary adjustments show potential in alleviating SIBO-related gastrointestinal symptoms.
- A low FODMAP diet, commonly used for IBS, might negatively impact gut microbiota and exacerbate dysbiosis in SIBO patients.
- Soluble fiber supplementation and targeted probiotics may improve IBS and SIBO symptoms and enhance antibiotic treatment efficacy.
Conclusions:
- Optimal dietary patterns are essential for effective SIBO management.
- The efficacy of standard IBS diets for SIBO is currently hypothetical and requires further research.
- Future studies should focus on developing specific dietary guidelines tailored for SIBO treatment.
More Related Videos
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:21Drugs for Treatment of Constipation-Predominant IBS
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are: